933-98 Temporal Correlation of Changes in Left Ventricular Mass with Myosin Isoform mRNAs in Spontaneously Hypertensive Rats Treated with Quinapril or Hydralazine  by Susic, Dinko et al.
lACC February 1995 ABSTRACfS I2IA
Maximum QTc was significantly correlated with LVMI (r = 0.41, P < 0.01),
systolic BP(r = 0.43, P < 0.01), E/A ratio (r = -0.33, P < 0.01 I. IVRT (r ~ 0.35, P
< 0.011 and age (r = 0.30, P < 0.01). QTc dispersion was similarly significantly
correlated with LVMI (r = 0.30, p < 0.011. systolic BP (r = 030, P < 0.01 L
E/A ratio (r = -0.22, P = 0.02), IVRT (r = 0.31, P < 0.01) and age (r = 0.21, P
< 0.04). The interdependence of these factors preclude multiple regression
analysis.
In conclusion, QT dispersion and maximum QT length are related to left
ventricular structure and diastolic function. This may reflect an increase in
dispersion of recovery of ventricular excitability occurring as a result of the
myocardial structural changes that occur as a consequence of hypertension.
This may in turn predispose to ventricular arrhythmias which could help ex-
plain the high incidence of sudden death in hypertensives with LVH.
Matthew J. Schnellbaecher, Aasha S. Gopal, Lawrence M. Boxt. Jose Katz,
Kathleen Reagan, Zhanqing Shen, Peter M. Sapin, Olakunle O. Akinboboye,
Andrew M. Keller, Donald L. King. Columbia University; New York, New York
Measurement of LV mass and its regression is important in dilated and con-
genitally deformed ventricles as well as in those with normal shape and con-
centric hypertrophy. Conventional echo methods for mass estimation use ge-
ometric and image plane positioning assumptions that may be invalid in pa-
tients with abnormally shaped ventricles. 3D echo eliminates these assump-
tions and has been previously validated for LV mass determination in normally
shaped ventricles (r = 0.93, SEE = 9-11 g). In the same study Penn conven-
tion and 2D echo methods had standard errors greater than two times larger
than 3D echo. Purpose; To compare LV mass determination by 3D echo and
MRI in patients with abnormal ventricular shape. Methods; 30 patients under-
went 3D echo and short-axis gradient reversal MRI within 6 hours. 3D echo
data sets of 8-10 short axis, non-parallel, non-intersecting short axis cross-
sections were obtained using an acoustic spatial locater and a line of inter-
section display for guidance. End-diastolic image data sets were obtained,
boundaries were traced manually and mass computed. Etiologies of abnor-
mal ventricular shape included ischemic, idiopathic, congenital, valvular and
alcoholic cardiac disease. Results were compared by linear regression and
limits of agreement analysis. Results;
Mltsuhiro Yokota, Akiko Noda, Fumihiko Yasuma, Takashi Miyahara,
Tamotsu Okada. Department of Clinicall..1Jboratory Medicine, Nagoya University
School of Medicine, Nagoya, Japan
Fifty-one middle-aged male patients with obstructive sleep apnea syn-
drome (OSAS) were evaluated using two dimensional echocardiography, 24-
hour blood pressure measurements, polysomnography, and plasma nore-
pinephrine (NE) measurements.
Among these patients, left ventricular hypertrophy (LVH) (left ventricular
posterior wall thickness (LVPWT) or interventricular septal thickness (IVST) :::
12 mm), and right ventricular hypertrophy (RVH) (right ventricular wall thick-
ness (RVT) ::: 5 mm) were present in 41.2% (21/51) and 11.8% (6/51). LVH
was present in 50.0% of group II (apnea index >20) patients and in 30.5% of
group I patients (apnea index <20). All patients with LVH had hypertension.
RVH was present 21.4% in group II patients and none of the group I patients.
IVST, LVPWT, LV mass and obesity index were significantly higher in group
II than group I. LV mass was significantly correlated with apnea index, the
duration of nocturnal oxygen saturation less than 90%, 24-hour mean blood
pressure, weight, BSA, and obesity index. Apnea index, number of apnea,
duration of nocturnal oxygen desaturation less than 90%, weight, and obesity
index were signific'antly greater in patients with both LVH and RVH than in
patients without LVH or RVH, or those with only LVH.
Plasma NE after waking up significantly increased compared with that be-
fore sleep (p < 0.05). The ratio of plasma NE levels after waking up to those
before sleep was significantly correlated with the duration of nocturnal oxy-
gen desaturation less than 90% (r = 0.83, p < 0.05). but not with apnea index.
These results suggest that frequent episodes of oxygen desaturation
andlor arousal response caused by apnea may contribute to the complica-
tion of LVH and RVH in the long term, and apnea-induced cyclical increase in
blood pressure and the resulting sustained elevation in blood pressure asso-
ciated with the increase in afterload sympathetic activity may playa role in
the development of LVH.
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Do Cardiac Structural Changes Progress in
Parallel with Extracardiac Target Organ Damage
in Essential Hypertension?
Limits of Agreement:
Linear Regression: Range: 863-400.3 g; Mean = 205.7 ± 828
r = 0.82; SEE = 34.9 g; P < 0.001
3D ECHO ~ 0.59 MRI + 72.8 9
Bias (mean of differences) = -11.4 9
Limits (2 SD of differences) ~ 96.4 9
Conclusions; Left ventricular mass determination by 3D echo is clinically
feasible. Initial clinical experience in unselected patients with abnormal ven-
tricles demonstrates good correlation and standard error, small bias and ac-
ceptable limits of agreement with MRI. 3D echo offers a new means for clini-
cal assessment of LV mass.
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YUli Shigematsu, Mareomi Hamada, Hideo Kawakami, Yutaka Hayashi,
Takamasa Kobayashi, Hideki Okayama, Mikio Mukai, Takumi Sumimoto,
Kunio Hiwada. Ehime University; Ehime, Japan
This study was designed to determine whether cardiac structural changes
progress in parallel with extracardiac target organ damage in essential hyper-
tension. One hundred and fourty patients with essential hypertension were
subdivided into 4 groups based on left ventricular mass index (LVMI) and rel-
ative wall thickness (RWTI. With respect to extracardiac target organ dam-
age, we measured Keith-Wagener (K-WI classification of retinal changes and
serum creatinine (sCr) level. In addition, we studied the clinical significance
of neurohumoral factors for cardiovascular structural changes. Among hyper-
tensive patients, LVM I and RWT were normal in 45% (group 1), whereas 14%
had increased RWT with normal LVMI (group 2), 14% had concentric hyper-
trophy (increase in both variables) (group 3) and 27% had increased LVMI and
normal RWT. All values are expressed as mean ± SD.
Temporal Correlation of Changes in Left
Ventricular Mass with Myosin Isoform mRNAs in
Spontaneously Hypertensive Rats Treated with
Quinapril or Hydralazine
Dinko Susic, Eduardo Nunez, Edward D. Frohlich, Om Prakash. Alton Ochsner
Medical Foundauon, New Orleans, LA
# P< 0.05 vo group 1. 'p < 005 vs group 2, +p < 005 vo group 3
In a multiple regression model, there was a strongly significant correlation
between the degree of LVMI and the severity of hypertensive retinopathy and
renal insufficiency independent of office blood pressure. Plasma renin activity
and plasma aldosterone concentration in group 3 were significantly higher
than those in remaining three groups.
Conclusions; 1) Cardiac structural changes in essential hypertension
progress in parallel with extracardiac target organ damage; 2) Renin-
angiotensin-aldosterone system appears to be one of the important factors
which link cardiac structural changes and extracardiac target organ damage.
During the development of hypertensive left ventricular hypertrophy (LVH)
myosin isoforms change from a-myosin (aM) to p-myosin (PM). In this
study the effect of therapeutic decreases in hemodynamic loads on LVH and
myosin mRNA expression of LV myocardium were examined in 19-week old
spontaneously hypertensive rats (SHR). SHR were divided into 3 groups re-
ceiving: quinapril (Q) (3 mg/kg); hydralazine (Hy) (1 mglkg); or placebo IC) p.o
daily. Four rats from each group were examined on days 0, 2, 4, 7,10, and 21.
Mean arterial pressure and total peripheral reasistance were significantly and
similarly reduced in 0 and Hy groups beginning day 4; there was no change
in cardiac output (thermodilution). No changes in any hemodynamic variable
occured in group C. Total RNA was isolated and analyzed by blot hybridiza-
tion technique using labeled probes for aM, PM, and GAPDH (a "houskeep-
ing gene"l. After autoradiographic exposure films were analyzed by densit-
ometry. After normalization for GAPDH, the relative amounts of aM and pM
mRNAs were expressed in relation to day O.
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% of patients with LVH Precordial Voltage
SL+ MC (mV.101
RX Base 3 mos 1yr Base 3 mos 1yr Base 3 mas 1yr
AT 12 +9* +9 17 +7# +15 27.1 +0.6 -0.1
CP 23 -8* -4 33 -7 -4 281 0 +0.2
CL 16 +3 0 22 +5 +2 28.4 +0.3 -0.4
DT 18 +5 +8 29 +6 +16@ 300 -0.9 -0.5
HZ 26 -5 -9 41 -8# -9@ 29.4 -0.5 -1.5
PZ 23 +1 -4 33 -1 +3 28.4 -0.1 +07
PL 16 +5 25 +7 28.3 +0.4 +1.1
* AT v CP 3 mos, # HZ v AT 3 mos, @ HZ v DZ 1 yr (p < 0.05)
Thus, HZ caused a decrease in LVH prevalence, while AT and DT caused an
increase. These changes are concordant with echo observations, where HZ
was the only drug to significantly reduce LV mass for equal levels of systolic
BP reduction.
Unstable angina
Lesion length::: 10 mm
Angulation >45"
Independent Predictors
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Incidence of and Factors Associated with Abrupt
Closure in Patients Undergoing Elective, New Device
Angioplasty in Native Coronary Arteries
Mun K. Hong, Jeffrey J. Popma, S. Chiu Wong, Kenneth M. Kent, Augusto
D. Pichard, Lowell F. Satler, Ya Chien Chuang, Theresa A. Bucher, S. Shareghi,
Martin B. Leon. Washington Hospital Center. Washington, D.C.
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Complications of Coronary Intervention:
Prediction and Management
Monday, March 20, 1995,4:00 p.m.-5:30 p.m.
Ernest N. Morial Convention Center, Room 90
The sole independent predictor for out-of-Iab only abrupt closure was dis-
section (Odds Ratio = 3.11, p < 0.005). We conclude that; (1) The incidence
of abrupt closure (both in- and out-of-Iab) was 3.9% in patients undergoing
elective new device angioplasty, with nearly equal distribution of in- and out-
of-lab occurrences: (2) Unstable angina. lesion length ~ 10 mm, and angula-
tion ~45° predicted either in- or out-of-Iab abrupt closure, whereas dissection
was the sole significant predictor of out-of-Iab only abrupt closure: and (3)
both lesion-related (thrombus-containing lesions for extraction atherectomy)
and device-related factors (stents with subacute thrombosis) added to the
acceptable rates of abrupt closure with these new devices for lesions unfa-
vorable for conventional angioplasty.
c.1. = confidence interval
To determine the incidence and predictors of abrupt closure (TIMI flow = 0
or 1) in patients undergoing new device angioplasty (NDA). we studied the
hospital records and qualitative morphologic and quantitative angiographic
methods of 1,983 patients with unfavorable lesion morphologies treated
electively in native coronary arteries with intracoronary stents (N = 96), ex-
traction atherectomy (TEC; N = 27). directional atherectomy (N = 563), ro-
tational atherectomy (N = 775), or laser (N = 522). The overall incidence
of abrupt closure was 3.9% (78/1983), with 2.1 % (42/78) occurring during
the procedure and 1.8% (36/78) occurring out-of-Iab (1 patient with both in-
and out-of-Iab abrupt closure). Among NDA. TEC (14.8%) and stents (8.3%)
had relatively higher frequencies of abrupt closure compared to other NDAs
(mean of 3.5%). Multivariate analysis of demographic and lesion characteris-
tics revealed the following predictors associated with either in-lab or out-of-
lab abrupt closure:
lACC February 1995
1720-21 Predictors of Acute Complications After
Percutaneous Coronary Revascularization with New
Devices
Peter A. McCullough, William W. O'Neill, Melissa May, Anne Lichtenberg,
Michelle Strzelecki, Cindy L. Grines, Robert D. Safian. William Beaumont Hospital,
Royal Oak, MI
Studies of conventional balloon angioplasty (PTCA) have identified female
gender, age, unstable angina. prior coronary bypass surgery. diabetes, le-
sion thrombus, and dissection as predictors of acute complications, but pre-
dictors of the risks of new device interventions are unknown. New devices
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Days Control Ouinapril Hydralazine
LVMI aM ,IlM LVMI aM ,IlM LVMI aM ,IlM
0 2.66 1.0 1.0 2.66 1.0 10 266 1.0 1.0
2 2.61 12 1.1 255 15 0.8 2.60 1.5 1.1
4 2.62 0.8 0.8 2.59 2.3* OS 2.64 1.6 0.6
7 2.74 0.9 0.9 2.37* 1.9* 07 2.48 2.1* 0.6
10 2.74 0.9 1.3 2.39* 2.5* 0.5* 2.81 1.1' 0.5*
21 270 1.2 1.2 2.35* 2.5* 0.5* 2.58 1.9* 0.4*
Group N MAP MAF SAR + DP/DT LVMI V1 V2 V3
Placebo 17 151* 105* 1.57* 16246* 2.98 ns 32* 23 45*
Hydralazine 18 104 164 067 8562 280 68 15 17
Enalapril 13 94 144 0.68 8633 2.19# 80 11 9
Control 11 85 179 0.49 13022 255 60 15 25
Chronic Hydralazine or Enalapril Normalize
Myosin Isoforms in the Spontaneously
Hypertensive Rat, but Only Enalapril Normalizes
Left Ventricular Mass
Garrie J. Haas, Margaret Ginn Pease, Melinda Hunnicutt, Mary E. Allon, A.
John Merola, Robert J. Cody. The Ohio State University. Columbus, Ohio
These data show that reduction in hemodynamic load induced a change in
myosin isoforms to adult pattern whereas only Q reduced LVMI, suggesting
that LVH reversal may not be dependent solely on hemodynamic load.
Increased V3 myosin isoform is seen in left ventricular (LV) hypertrophy (H),
but reversion to V1 with chronic afterload reduction and LVH regression is
not well defined. We randomized SHR at 3-4 months to oral hydralazine (25
mglkg), enalapril (40 mglkg), or placebo. Age matched Wistar Kyoto rats were
controls. Group average systolic blood pressure (mmHg) at baseline was
207 (Plac), 223 (Hydrl), 225 (Enal), and 156 (Cntrl). Rats were studied after
3 months of treatment. Echocardiographic LVmass (LVM) was from the cu-
bic function: LVM (mg) = 1.04[(EDD + PWT + IVS)3 - EDD3]. corrected for
body weight (LVMI), since echocardiography permits better identification of
differing patterns of hypertrophy. Terminal hemodynamics were volumetric
aortic flow (mean: MAF, mllmin) and Millar aortic pressure (mean: MAP). Sys-
temic arterial resistance (SAR) and LV contractility (+dp/dt) was derived from
digitized waveforms. Following termination, LV was harvested and frozen at
-8000 C, and myosin isoforms were determined bygel electrophoresis, with
expression of V1, V2, V3 isoforms as % total. Analysis of variance was per-
formed and group mean values are given below:
LVMI-LV mass index. *p < 0.05, compared with day 0 (same group) or control
*p <. 05, placebo vs Hydrl. and vs Enal. # p < 0.05 placebo vs Enal
Thus, myosin isoform expression reverted to an adult pattern, in response
to long term afterload reduction. Changes in myosin transcriptional patterns
however, require additional assessment. Eccentric hypertrophy accounted
for persistent LVMI following hydralazine, whereas greater LVMI reduction
occurred with ACE inhibition. This suggests that factors other than afterload
reduction contribute to LVMI regression with ACE inhibition.
Both ECG and echo LVH are markers of increased risk, but there is much
less information on interdrug differences in ECG LVH regression. Therefore,
changes in ECG LVH prevalence were examined after 3 mas titration phase
and a 1 yr maintenance phase of randomized double-blind treatment with
atenolol (AT), captopril (CP). clonidine (CL). diltiazem (DT). hydrochloroth-
iazide (HZ), prazosin (PZ) or placebo (PL) in 570 men with mild-moderate hy-
pertension. The prevalence of Sokolow-Lyon (SL) and Minnesota code (MC)
criteria were evaluated, as well as precordial voltage (Svl + Rv5). Percent
changes from baseline were:
Effect of 6 Antihypertensive Drugs on ECG Left
Ventricular Hypertrophy
Vasilios Papademetriou, Elaine Der, John Gottdiener, Barry Materson,
Domenic Reda, Barry M. Massie, VA Monotherapy of Hypertension Study Group.
VAMC and UCSF, San Francisco, CA; Georgetown University Medical Center.
Washington DC
